September 2021 Markets
MARKETS AND ECONOMICS September was a relatively volatile month across many markets, as investors continue to digest and to react to the spread of the Delta variant, the timeline for…
MARKETS AND ECONOMICS September was a relatively volatile month across many markets, as investors continue to digest and to react to the spread of the Delta variant, the timeline for…
MARKETS AND ECONOMICS Global markets provided strong returns for August amidst many market-moving events and news, including significant geopolitical tension from the situation in Afghanistan and continued regulatory intervention in…
MARKETS AND ECONOMICS Market performance was relatively mixed for June, especially among equity markets, while bond yields ended mostly higher. Apart from a few areas of performance, it seems that…
MARKETS AND ECONOMICS We have firmly entered the end of the first half of 2021 with another busy month that has passed: from inflation scares, a crypto-crash, conflict in the…
MARKETS AND ECONOMICS April provided another strong batch of returns as general positive sentiment, driven by increasing levels of global stimulus, stronger global growth combined with a weakening United States…
From a global perspective, the South African All Share Index outperformed most of the major equity indices (S&P 500, FTSE 100, Nikkei 225, Hang Seng, FSE DAX) in local currency.…
This first batch of approximately one million vaccinations will be used for healthcare workers, with a second batch expected towards the end of February. According to comments from government, they…
This first batch of approximately one million vaccinations will be used for healthcare workers, with a second batch expected towards the end of February. According to comments from government, they…
COVID AND VACCINES Festive moods were significantly dampened over December as infection rates skyrocketed and the second wave firmly took hold in South Africa (SA). This led to tighter lockdown…
Financial markets delivered on the expectations of much better performance in November relative to prior months. Buoyed by optimism around the development and success of COVID-19 vaccines, progress in the…